Liquid biopsy is an emerging and non-invasive method of genetic testing, which is applicable to a variety of symptoms and a wide range of applications.

The global Liquid Tumor Biopsy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Liquid Tumor Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Liquid Tumor Biopsy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Liquid Tumor Biopsy in Clinical Laboratories is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Liquid Tumor Biopsy include Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann-La Roche, Illumina, QIAGEN N.V., Thermo Fisher Scientific, Amoy Diagnostics, HaploX and Whole Genome Sequencing, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Liquid Tumor Biopsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Tumor Biopsy.

Report Scope

The Liquid Tumor Biopsy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid Tumor Biopsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liquid Tumor Biopsy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Liquid Tumor Biopsy Market Report

Report Metric	Details
Report Name	Liquid Tumor Biopsy Market
Segment by Type	ctDNA CTC
Segment by Application	Clinical Laboratories Hospital
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann-La Roche, Illumina, QIAGEN N.V., Thermo Fisher Scientific, Amoy Diagnostics, HaploX, Whole Genome Sequencing, Burning Rock Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Tumor Biopsy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Liquid Tumor Biopsy Market report?

Ans: The main players in the Liquid Tumor Biopsy Market are Abbott Laboratories, Bio-Rad Laboratories, F. Hoffmann-La Roche, Illumina, QIAGEN N.V., Thermo Fisher Scientific, Amoy Diagnostics, HaploX, Whole Genome Sequencing, Burning Rock Biotech

What are the Application segmentation covered in the Liquid Tumor Biopsy Market report?

Ans: The Applications covered in the Liquid Tumor Biopsy Market report are Clinical Laboratories, Hospital

What are the Type segmentation covered in the Liquid Tumor Biopsy Market report?

Ans: The Types covered in the Liquid Tumor Biopsy Market report are ctDNA, CTC

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Liquid Tumor Biopsy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 ctDNA

1.2.3 CTC

1.3 Market by Application

1.3.1 Global Liquid Tumor Biopsy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Laboratories

1.3.3 Hospital

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Liquid Tumor Biopsy Market Perspective (2019-2030)

2.2 Liquid Tumor Biopsy Growth Trends by Region

2.2.1 Global Liquid Tumor Biopsy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Liquid Tumor Biopsy Historic Market Size by Region (2019-2024)

2.2.3 Liquid Tumor Biopsy Forecasted Market Size by Region (2025-2030)

2.3 Liquid Tumor Biopsy Market Dynamics

2.3.1 Liquid Tumor Biopsy Industry Trends

2.3.2 Liquid Tumor Biopsy Market Drivers

2.3.3 Liquid Tumor Biopsy Market Challenges

2.3.4 Liquid Tumor Biopsy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Liquid Tumor Biopsy Players by Revenue

3.1.1 Global Top Liquid Tumor Biopsy Players by Revenue (2019-2024)

3.1.2 Global Liquid Tumor Biopsy Revenue Market Share by Players (2019-2024)

3.2 Global Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Liquid Tumor Biopsy Revenue

3.4 Global Liquid Tumor Biopsy Market Concentration Ratio

3.4.1 Global Liquid Tumor Biopsy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Liquid Tumor Biopsy Revenue in 2023

3.5 Liquid Tumor Biopsy Key Players Head office and Area Served

3.6 Key Players Liquid Tumor Biopsy Product Solution and Service

3.7 Date of Enter into Liquid Tumor Biopsy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Liquid Tumor Biopsy Breakdown Data by Type

4.1 Global Liquid Tumor Biopsy Historic Market Size by Type (2019-2024)

4.2 Global Liquid Tumor Biopsy Forecasted Market Size by Type (2025-2030)

5 Liquid Tumor Biopsy Breakdown Data by Application

5.1 Global Liquid Tumor Biopsy Historic Market Size by Application (2019-2024)

5.2 Global Liquid Tumor Biopsy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Liquid Tumor Biopsy Market Size (2019-2030)

6.2 North America Liquid Tumor Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Liquid Tumor Biopsy Market Size by Country (2019-2024)

6.4 North America Liquid Tumor Biopsy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Liquid Tumor Biopsy Market Size (2019-2030)

7.2 Europe Liquid Tumor Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Liquid Tumor Biopsy Market Size by Country (2019-2024)

7.4 Europe Liquid Tumor Biopsy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Liquid Tumor Biopsy Market Size (2019-2030)

8.2 Asia-Pacific Liquid Tumor Biopsy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2019-2024)

8.4 Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Liquid Tumor Biopsy Market Size (2019-2030)

9.2 Latin America Liquid Tumor Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Liquid Tumor Biopsy Market Size by Country (2019-2024)

9.4 Latin America Liquid Tumor Biopsy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Liquid Tumor Biopsy Market Size (2019-2030)

10.2 Middle East & Africa Liquid Tumor Biopsy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2019-2024)

10.4 Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott Laboratories

11.1.1 Abbott Laboratories Company Detail

11.1.2 Abbott Laboratories Business Overview

11.1.3 Abbott Laboratories Liquid Tumor Biopsy Introduction

11.1.4 Abbott Laboratories Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.1.5 Abbott Laboratories Recent Development

11.2 Bio-Rad Laboratories

11.2.1 Bio-Rad Laboratories Company Detail

11.2.2 Bio-Rad Laboratories Business Overview

11.2.3 Bio-Rad Laboratories Liquid Tumor Biopsy Introduction

11.2.4 Bio-Rad Laboratories Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.2.5 Bio-Rad Laboratories Recent Development

11.3 F. Hoffmann-La Roche

11.3.1 F. Hoffmann-La Roche Company Detail

11.3.2 F. Hoffmann-La Roche Business Overview

11.3.3 F. Hoffmann-La Roche Liquid Tumor Biopsy Introduction

11.3.4 F. Hoffmann-La Roche Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.3.5 F. Hoffmann-La Roche Recent Development

11.4 Illumina

11.4.1 Illumina Company Detail

11.4.2 Illumina Business Overview

11.4.3 Illumina Liquid Tumor Biopsy Introduction

11.4.4 Illumina Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.4.5 Illumina Recent Development

11.5 QIAGEN N.V.

11.5.1 QIAGEN N.V. Company Detail

11.5.2 QIAGEN N.V. Business Overview

11.5.3 QIAGEN N.V. Liquid Tumor Biopsy Introduction

11.5.4 QIAGEN N.V. Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.5.5 QIAGEN N.V. Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Detail

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Liquid Tumor Biopsy Introduction

11.6.4 Thermo Fisher Scientific Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Amoy Diagnostics

11.7.1 Amoy Diagnostics Company Detail

11.7.2 Amoy Diagnostics Business Overview

11.7.3 Amoy Diagnostics Liquid Tumor Biopsy Introduction

11.7.4 Amoy Diagnostics Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.7.5 Amoy Diagnostics Recent Development

11.8 HaploX

11.8.1 HaploX Company Detail

11.8.2 HaploX Business Overview

11.8.3 HaploX Liquid Tumor Biopsy Introduction

11.8.4 HaploX Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.8.5 HaploX Recent Development

11.9 Whole Genome Sequencing

11.9.1 Whole Genome Sequencing Company Detail

11.9.2 Whole Genome Sequencing Business Overview

11.9.3 Whole Genome Sequencing Liquid Tumor Biopsy Introduction

11.9.4 Whole Genome Sequencing Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.9.5 Whole Genome Sequencing Recent Development

11.10 Burning Rock Biotech

11.10.1 Burning Rock Biotech Company Detail

11.10.2 Burning Rock Biotech Business Overview

11.10.3 Burning Rock Biotech Liquid Tumor Biopsy Introduction

11.10.4 Burning Rock Biotech Revenue in Liquid Tumor Biopsy Business (2019-2024)

11.10.5 Burning Rock Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

Amoy Diagnostics

Haplox

Burning Rock Biotech

Whole Genome Sequencing

List of Tables

Table 1. Global Liquid Tumor Biopsy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of ctDNA

Table 3. Key Players of CTC

Table 4. Global Liquid Tumor Biopsy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Liquid Tumor Biopsy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Liquid Tumor Biopsy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Liquid Tumor Biopsy Market Share by Region (2019-2024)

Table 8. Global Liquid Tumor Biopsy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Liquid Tumor Biopsy Market Share by Region (2025-2030)

Table 10. Liquid Tumor Biopsy Market Trends

Table 11. Liquid Tumor Biopsy Market Drivers

Table 12. Liquid Tumor Biopsy Market Challenges

Table 13. Liquid Tumor Biopsy Market Restraints

Table 14. Global Liquid Tumor Biopsy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Liquid Tumor Biopsy Market Share by Players (2019-2024)

Table 16. Global Top Liquid Tumor Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Tumor Biopsy as of 2023)

Table 17. Ranking of Global Top Liquid Tumor Biopsy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Liquid Tumor Biopsy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Liquid Tumor Biopsy Product Solution and Service

Table 21. Date of Enter into Liquid Tumor Biopsy Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Liquid Tumor Biopsy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Liquid Tumor Biopsy Revenue Market Share by Type (2019-2024)

Table 25. Global Liquid Tumor Biopsy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Liquid Tumor Biopsy Revenue Market Share by Type (2025-2030)

Table 27. Global Liquid Tumor Biopsy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Liquid Tumor Biopsy Revenue Market Share by Application (2019-2024)

Table 29. Global Liquid Tumor Biopsy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Liquid Tumor Biopsy Revenue Market Share by Application (2025-2030)

Table 31. North America Liquid Tumor Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Liquid Tumor Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Liquid Tumor Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Liquid Tumor Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Liquid Tumor Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Liquid Tumor Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Liquid Tumor Biopsy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Liquid Tumor Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Liquid Tumor Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Liquid Tumor Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Liquid Tumor Biopsy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Abbott Laboratories Company Detail

Table 47. Abbott Laboratories Business Overview

Table 48. Abbott Laboratories Liquid Tumor Biopsy Product

Table 49. Abbott Laboratories Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 50. Abbott Laboratories Recent Development

Table 51. Bio-Rad Laboratories Company Detail

Table 52. Bio-Rad Laboratories Business Overview

Table 53. Bio-Rad Laboratories Liquid Tumor Biopsy Product

Table 54. Bio-Rad Laboratories Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 55. Bio-Rad Laboratories Recent Development

Table 56. F. Hoffmann-La Roche Company Detail

Table 57. F. Hoffmann-La Roche Business Overview

Table 58. F. Hoffmann-La Roche Liquid Tumor Biopsy Product

Table 59. F. Hoffmann-La Roche Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 60. F. Hoffmann-La Roche Recent Development

Table 61. Illumina Company Detail

Table 62. Illumina Business Overview

Table 63. Illumina Liquid Tumor Biopsy Product

Table 64. Illumina Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 65. Illumina Recent Development

Table 66. QIAGEN N.V. Company Detail

Table 67. QIAGEN N.V. Business Overview

Table 68. QIAGEN N.V. Liquid Tumor Biopsy Product

Table 69. QIAGEN N.V. Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 70. QIAGEN N.V. Recent Development

Table 71. Thermo Fisher Scientific Company Detail

Table 72. Thermo Fisher Scientific Business Overview

Table 73. Thermo Fisher Scientific Liquid Tumor Biopsy Product

Table 74. Thermo Fisher Scientific Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 75. Thermo Fisher Scientific Recent Development

Table 76. Amoy Diagnostics Company Detail

Table 77. Amoy Diagnostics Business Overview

Table 78. Amoy Diagnostics Liquid Tumor Biopsy Product

Table 79. Amoy Diagnostics Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 80. Amoy Diagnostics Recent Development

Table 81. HaploX Company Detail

Table 82. HaploX Business Overview

Table 83. HaploX Liquid Tumor Biopsy Product

Table 84. HaploX Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 85. HaploX Recent Development

Table 86. Whole Genome Sequencing Company Detail

Table 87. Whole Genome Sequencing Business Overview

Table 88. Whole Genome Sequencing Liquid Tumor Biopsy Product

Table 89. Whole Genome Sequencing Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 90. Whole Genome Sequencing Recent Development

Table 91. Burning Rock Biotech Company Detail

Table 92. Burning Rock Biotech Business Overview

Table 93. Burning Rock Biotech Liquid Tumor Biopsy Product

Table 94. Burning Rock Biotech Revenue in Liquid Tumor Biopsy Business (2019-2024) & (US$ Million)

Table 95. Burning Rock Biotech Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Liquid Tumor Biopsy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Liquid Tumor Biopsy Market Share by Type: 2023 VS 2030

Figure 3. ctDNA Features

Figure 4. CTC Features

Figure 5. Global Liquid Tumor Biopsy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Liquid Tumor Biopsy Market Share by Application: 2023 VS 2030

Figure 7. Clinical Laboratories Case Studies

Figure 8. Hospital Case Studies

Figure 9. Liquid Tumor Biopsy Report Years Considered

Figure 10. Global Liquid Tumor Biopsy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Liquid Tumor Biopsy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Liquid Tumor Biopsy Market Share by Region: 2023 VS 2030

Figure 13. Global Liquid Tumor Biopsy Market Share by Players in 2023

Figure 14. Global Top Liquid Tumor Biopsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Tumor Biopsy as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Liquid Tumor Biopsy Revenue in 2023

Figure 16. North America Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Liquid Tumor Biopsy Market Share by Country (2019-2030)

Figure 18. United States Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Liquid Tumor Biopsy Market Share by Country (2019-2030)

Figure 22. Germany Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Liquid Tumor Biopsy Market Share by Region (2019-2030)

Figure 30. China Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Liquid Tumor Biopsy Market Share by Country (2019-2030)

Figure 38. Mexico Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Liquid Tumor Biopsy Market Share by Country (2019-2030)

Figure 42. Turkey Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Liquid Tumor Biopsy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Abbott Laboratories Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 45. Bio-Rad Laboratories Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 46. F. Hoffmann-La Roche Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 47. Illumina Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 48. QIAGEN N.V. Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 50. Amoy Diagnostics Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 51. HaploX Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 52. Whole Genome Sequencing Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 53. Burning Rock Biotech Revenue Growth Rate in Liquid Tumor Biopsy Business (2019-2024)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions